Medicare ACO cost incentives for potential prescribing shifts in cancer therapies worry stakeholdersJune 24, 2011
Pharmaceutical patient assistance programs in the outpatient pharmacy of a large tertiary cancer centerJune 24, 2011Patient & Survivor Care
New Payment Systems in Oncology: Aligning Incentives for Value and AccountabilityJune 3, 2011Business of Medicine
A Phase II Tolerability Trial of Neoadjuvant Docetaxel with Carboplatin and Capecitabine in Locally Advanced Breast CancerMay 25, 2011Breast Cancer
Hydroxyurea-induced palmar-plantar erythrodysesthesia in an adult with sickle cell diseaseMay 25, 2011Patient & Survivor Care
CASE LETTER Hydroxyurea-induced palmar-plantar erythrodysesthesia in an adult with sickle cell diseaseMay 1, 2011Leukemia, Myelodysplasia, Transplantation
